As of 2025-07-19, the EV/EBITDA ratio of Cue Biopharma Inc (CUE) is -1.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CUE's latest enterprise value is 58.05 mil USD. CUE's TTM EBITDA according to its financial statements is -40.82 mil USD. Dividing these 2 quantities gives us the above CUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 13.1x | 12.7x |
| Forward P/E multiples | 17.0x - 31.9x | 20.5x |
| Fair Price | (9.09) - (6.95) | (8.86) |
| Upside | -1110.2% - -871.8% | -1084.9% |
| Date | EV/EBITDA |
| 2025-07-16 | -1.34 |
| 2025-07-15 | -1.05 |
| 2025-07-14 | -1.20 |
| 2025-07-11 | -1.17 |
| 2025-07-10 | -1.23 |
| 2025-07-09 | -1.21 |
| 2025-07-08 | -1.11 |
| 2025-07-07 | -1.05 |
| 2025-07-03 | -1.04 |
| 2025-07-02 | -1.04 |
| 2025-07-01 | -1.00 |
| 2025-06-30 | -1.02 |
| 2025-06-27 | -1.13 |
| 2025-06-26 | -1.22 |
| 2025-06-25 | -1.21 |
| 2025-06-24 | -1.10 |
| 2025-06-23 | -0.97 |
| 2025-06-20 | -1.05 |
| 2025-06-18 | -0.97 |
| 2025-06-17 | -0.83 |
| 2025-06-16 | -0.85 |
| 2025-06-13 | -0.87 |
| 2025-06-12 | -0.93 |
| 2025-06-11 | -0.94 |
| 2025-06-10 | -0.93 |
| 2025-06-09 | -0.94 |
| 2025-06-06 | -0.94 |
| 2025-06-05 | -0.92 |
| 2025-06-04 | -0.91 |
| 2025-06-03 | -0.93 |
| 2025-06-02 | -0.97 |
| 2025-05-30 | -0.94 |
| 2025-05-29 | -0.95 |
| 2025-05-28 | -0.92 |
| 2025-05-27 | -0.98 |
| 2025-05-23 | -0.98 |
| 2025-05-22 | -1.07 |
| 2025-05-21 | -0.87 |
| 2025-05-20 | -1.00 |
| 2025-05-19 | -1.07 |
| 2025-05-16 | -1.10 |
| 2025-05-15 | -1.10 |
| 2025-05-14 | -1.14 |
| 2025-05-13 | -1.18 |
| 2025-05-12 | -1.15 |
| 2025-05-09 | -1.20 |
| 2025-05-08 | -1.18 |
| 2025-05-07 | -1.18 |
| 2025-05-06 | -1.15 |
| 2025-05-05 | -1.20 |